Alkaline activation of ceramic waste materials

Ceramic materials represent around 45 % of construction and demolition waste, and originate not only from the building process, but also as rejected bricks and tiles from industry. Despite the fact that these wastes are mostly used as road sub-base or construction backfill materials, they can also be employed as supplementary cementitious materials, or even as raw material for alkali-activated binders This research aimed to investigate the properties and microstructure of alkali-activated cement pastes and mortars produced from ceramic waste materials of various origins. Sodium hydroxide and sodium silicate were used to prepare the activating solution. The compressive strength of the developed mortars ranged between 22 and 41 MPa after 7 days of curing at 65 C, depending on the sodium concentration in the solution and the water/binder ratio. These results demonstrate the possibility of using alkaliactivated ceramic materials in building applications.The authors are grateful to the Spanish Ministry of Science and Innovation for supporting this study through Project GEOCEDEM BIA 2011-26947, and also to FEDER funding. They also thank Universitat Jaume I for supporting this research through Lucia Reig's granted research stay.Reig Cerdá, L.; Mitsuuchi Tashima, M.; Soriano, L.; Borrachero Rosado, MV.; Monzó Balbuena, JM.; Paya Bernabeu, JJ. (2013). Alkaline activation of ceramic waste materials. Waste and Biomass Valorization. 4:729-736. https://doi.org/10.1007/s12649-013-9197-zS7297364Puertas, F., García-Díaz, I., Barba, A., Gazulla, M.F., Palacios, M., Gómez, M.P., Martínez-Ramírez, S.: Ceramic wastes as alternative raw materials for Portland cement clinker production. Cement Concrete Comp. 30(9), 798–805 (2008)Ministerio de Fomento de España, Catálogo de Residuos Utilizables en Construcción (2010). http://www.cedexmateriales.vsf.es/view/catalogo.aspx . Retrieved on 6 Dec 2012Stock, D.: World production and consumption of ceramic tiles. Tile Today 73, 50–58 (2011)Medina, C., Juan, A., Frías, M., Sánchez-de-Rojas, M.I., Morán, J.M., Guerra, M.I.: Characterization of concrete made with recycled aggregate from ceramic sanitary ware. Mater. Construcc. 61(304), 533–546 (2011)Pacheco-Torgal, F., Jalali, S.: Reusing ceramic wastes in concrete. Constr. Build. Mater. 24(5), 832–838 (2010)Lavat, A.E., Trezza, M.A., Poggi, M.: Characterization of ceramic roof tile wastes as pozzolanic admixture. Waste Manage. 29(5), 1666–1674 (2009)Nuran, A., Mevlut, U.: The use of waste ceramic tile in cement production. Cement Concrete Res. 30, 497–499 (2000)Pereira-de-Oliveira, L.A., Castro-Gomes, J.P., Santos, P.M.S.: The potential pozzolanic activity of glass and red-clay ceramic waste as cement mortars components. Constr. Build. Mater. 31, 197–203 (2012)Van Deventer, J.S.J., Provis, J.L., Duxson, P., Brice, D.G.: Chemical research and climate change as drivers in the commercial adoption of alkali activated materials. Waste Biomass Valor. 1, 145–155 (2010)van Deventer, J.S.J., Provis, J.L., Duxson, P., Lukey, G.C.: Reaction mechanisms in the geopolymeric conversion of inorganic waste to useful products. J. Hazard. Mater. A139, 506–513 (2007)Duxson, P., Fernández-Jiménez, A., Provis, J.L., Lukey, G.C., Palomo, A., van Deventer, J.S.J.: Geopolymer technology: the current state of the art. J. Mater. Sci. 42(9), 2917–2993 (2007)Bernal, S.A., Rodríguez, E.D., de Gutiérrez, R.M., Provis, J.L., Delvasto, S.: Activation of metakaolin/slag blends using alkaline solutions based on chemically modified silica fume and rice husk ash. Waste Biomass Valor. 3, 99–108 (2012)Fernández-Jiménez, A., Palomo, A., Criado, M.: Microstructure development of alkali-activated fly ash cement: a descriptive model. Cement Concrete Res 35, 1204–1209 (2005)Payá, J., Borrachero, M.V., Monzó, J., Soriano, L., Tashima, M.M.: A new geopolymeric binder from hydrated-carbonated cement. Mater. Lett. 74, 223–225 (2012)Kourti, I., Amutha-Rani, D., Deegan, D., Boccaccini, A.R., Cheeseman, C.R.: Production of geopolymers using glass produced from DC plasma treatment of air pollution control (APC) residues. J. Hazard. Mater. 176, 704–709 (2010)Puertas, F., Barba, A., Gazulla, M.F., Gómez, M.P., Palacios, M., Martínez-Ramírez, S.: Residuos cerámicos para su posible uso como materia prima en la fabricación de clínker de cemento Portland: caracterización y activación alcalina. Mater. Construcc. 56(281), 73–84 (2006)Reig, L., Tashima, M.M., Borrachero, M.V., Monzó, J., Payá, J.: Nuevas matrices cementantes generadas por Activación Alcalina de residuos cerámicos. II Simposio Aprovechamiento de residuos agro-industriales como fuente sostenible de materiales de construcción, November 8–9, Valencia, Spain, pp. 199–207 (2010)L. Reig, M.M. Tashima, M.V. Borrachero, J. Monzó, J. Payá: Residuos de ladrillos cerámicos en la producción de conglomerantes activados alcalinamente, I Pro-Africa Conference: Non-conventional Building Materials Based on Agroindustrial Wastes, October 18–19, Pirassununga, SP, Brazil, pp. 18–21 (2010)García Ten F.J. Descomposición durante la cocción del carbonato cálcico contenido en el soporte crudo de los azulejos. Tesis de doctorado, Departamento de Ingeniería química, UJI (2005)Baronio, G., Binda, L.: Study of the pozzolanicity of some bricks and clays. Constr. Build. Mater. 11(1), 41–46 (1997)Zanelli, C., Raimondo, M., Guarini, G., Dondi, M.: The vitreous phase of porcelain stoneware: composition, evolution during sintering and physical properties. J. Non-Cryst. Solids 357, 3251–3260 (2011)Carty, W.M., Senapati, U.: Porcelain-raw materials, processing, phase evolution, and mechanical behaviour. J. Am. Ceram. Soc. 81(1), 3–20 (1998)ASCER, COACV, COPUT, ITC-AICE, WEBER ET BROUTIN – CEMARKSA: Guía Baldosa Guía de la baldosa cerámica. IVE: Conselleria d’Obres Públiques, Urbanisme i Transports, 4ª Ed. Valencia (2003)Khater, H.M.: Effect of calcium on geopolimerization of aluminosilicate wastes. J. Mater. Civ. Eng. 24, 92–101 (2012)Bondar, D., Lynsdale, C.J., Milestone, N.B., Hassani, N., Ramezanianpour, A.A.: Effect of adding mineral additives to alkali-activated natural pozzolan paste. Constr. Build. Mater. 25, 2906–2910 (2011)Provis, J.L., Harrex, R.M., Bernal, A.S., Duxson, P., van Deventer, J.S.J.: Dilatometry of geopolymers as a means of selecting desirable fly ash sources. J. Non-Cryst. Solids 358, 1930–1937 (2012)Duxson, P., Provis, J.L., Lukey, G.C., Mallicoat, S.W., Kriven, W.M., van Deventer, J.S.J.: Understanding the relationship between geopolymer composition, microstructure and mechanical properties. Colloid Surf. A 269, 47–58 (2005)Tashima, M.M., Akasaki, J.L., Castaldelli, V.N., Soriano, L., Monzó, J., Payá, J., Borrachero, M.V.: New geopolymeric binder based on fluid catalytic cracking catalyst residue (FCC). Mater. Lett. 80, 50–52 (2012)Komnitsas, K., Zaharaki, D., Perdikatsis, V.: Geopolymerisation of low calcium ferronickel slags. J. Mater. Sci. 42, 3073–3082 (2007)Bernal, S.A., Gutierrez, R.M., Provis, J.L., Rose, V.: Effect of silicate modulus and metakaolin incorporation on the carbonation of alkali silicate-activated slags. Cement Concrete Res. 40, 898–907 (2010)Tashima, M.M. Produccion y caracterizacion de materiales cementantes a partir del silicoaluminato calcico vitreo (VCAS). Tesis de doctorado, Departamento de Ingeniería de la construcción y de proyectos de ingeniería civil, UPV (2012)Provis, J.L., van Deventer, J.S.J.: Geopolymerisation kinetics. 2. Reaction kinetic modelling. Chem. Eng. Sci. 62, 2318–2329 (2007

Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies

<p>Background - Various genome-wide association studies (GWAS) have been done in ischaemic stroke, identifying a few loci associated with the disease, but sample sizes have been 3500 cases or less. We established the METASTROKE collaboration with the aim of validating associations from previous GWAS and identifying novel genetic associations through meta-analysis of GWAS datasets for ischaemic stroke and its subtypes.</p> <p>Methods - We meta-analysed data from 15 ischaemic stroke cohorts with a total of 12 389 individuals with ischaemic stroke and 62 004 controls, all of European ancestry. For the associations reaching genome-wide significance in METASTROKE, we did a further analysis, conditioning on the lead single nucleotide polymorphism in every associated region. Replication of novel suggestive signals was done in 13 347 cases and 29 083 controls.</p> <p>Findings - We verified previous associations for cardioembolic stroke near PITX2 (p=2·8×10−16) and ZFHX3 (p=2·28×10−8), and for large-vessel stroke at a 9p21 locus (p=3·32×10−5) and HDAC9 (p=2·03×10−12). Additionally, we verified that all associations were subtype specific. Conditional analysis in the three regions for which the associations reached genome-wide significance (PITX2, ZFHX3, and HDAC9) indicated that all the signal in each region could be attributed to one risk haplotype. We also identified 12 potentially novel loci at p<5×10−6. However, we were unable to replicate any of these novel associations in the replication cohort.</p> <p>Interpretation - Our results show that, although genetic variants can be detected in patients with ischaemic stroke when compared with controls, all associations we were able to confirm are specific to a stroke subtype. This finding has two implications. First, to maximise success of genetic studies in ischaemic stroke, detailed stroke subtyping is required. Second, different genetic pathophysiological mechanisms seem to be associated with different stroke subtypes.</p&gt

Genetic Variation and Reproductive Timing: African American Women from the Population Architecture Using Genomics and Epidemiology (PAGE) Study

Age at menarche (AM) and age at natural menopause (ANM) define the boundaries of the reproductive lifespan in women. Their timing is associated with various diseases, including cancer and cardiovascular disease. Genome-wide association studies have identified several genetic variants associated with either AM or ANM in populations of largely European or Asian descent women. The extent to which these associations generalize to diverse populations remains unknown. Therefore, we sought to replicate previously reported AM and ANM findings and to identify novel AM and ANM variants using the Metabochip (n = 161,098 SNPs) in 4,159 and 1,860 African American women, respectively, in the Women's Health Initiative (WHI) and Atherosclerosis Risk in Communities (ARIC) studies, as part of the Population Architecture using Genomics and Epidemiology (PAGE) Study. We replicated or generalized one previously identified variant for AM, rs1361108/CENPW, and two variants for ANM, rs897798/BRSK1 and rs769450/APOE, to our African American cohort. Overall, generalization of the majority of previously-identified variants for AM and ANM, including LIN28B and MCM8, was not observed in this African American sample. We identified three novel loci associated with ANM that reached significance after multiple testing correction (LDLR rs189596789, p = 5×10-08; KCNQ1 rs79972789, p = 1.9×10-07; COL4A3BP rs181686584, p = 2.9×10-07). Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers (rs11604207, p = 1.6×10-06). While most associations were identified in either AM or ANM, we did identify genes suggestively associated with both: PHACTR1 and ARHGAP42. The lack of generalization coupled with the potentially novel associations identified here emphasize the need for additional genetic discovery efforts for AM and ANM in diverse populations. © 2013 Spencer et al

Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study

<p>Abstract</p> <p>Background</p> <p>Although plasma fibrinogen levels are related to cardiovascular risk, data regarding the role of fibrinogen genetic variation in myocardial infarction (MI) or coronary artery disease (CAD) etiology remain inconsistent. The purpose of the present study was to investigate the effect of <it>fibrinogen A (FGA)</it>, <it>fibrinogen B (FGB) </it>and <it>fibrinogen G (FGG) </it>gene SNPs and haplotypes on susceptibility to CAD in a homogeneous Greek population.</p> <p>Methods</p> <p>We genotyped for rs2070022, rs2070016, rs2070006 in <it>FGA </it>gene, the rs7673587, rs1800789, rs1800790, rs1800788, rs1800787, rs4681 and rs4220 in <it>FGB </it>gene and for the rs1118823, rs1800792 and rs2066865 SNPs in <it>FGG </it>gene applying an arrayed primer extension-based genotyping method (APEX-2) in a sample of CAD patients (n = 305) and controls (n = 305). Logistic regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs), before and after adjustment for potential confounders.</p> <p>Results</p> <p>None of the <it>FGA </it>and <it>FGG </it>SNPs and <it>FGA, FGB, FGG </it>and <it>FGA-FGG </it>haplotypes was associated with disease occurrence after adjustment. Nevertheless, rs1800787 and rs1800789 SNPs in <it>FGB </it>gene seem to decrease the risk of CAD, even after adjustment for potential confounders (OR = 0.42, 95%CI: 0.19-0.90, p = 0.026 and OR = 0.44, 95%CI:0.21-0.94, p = 0.039, respectively).</p> <p>Conclusions</p> <p><it>FGA </it>and <it>FGG </it>SNPs as well as <it>FGA, FGB, FGG </it>and <it>FGA-FGG </it>haplotypes do not seem to be important contributors to CAD occurrence in our sample. On the contrary, <it>FGB </it>rs1800787 and rs1800789 SNPs seem to confer protection to disease onset lowering the risk by about 50% in homozygotes for the minor alleles.</p

A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia

<p>Abstract</p> <p>Background</p> <p>Preeclampsia is a frequent complication of pregnancy and a leading cause of perinatal mortality. Both genetic and environmental risk factors have been identified. Lipid metabolism, particularly cholesterol metabolism, is associated with this disease. Liver X receptors alpha (NR1H3, also known as LXRalpha) and beta (NR1H2, also known as LXRbeta) play a key role in lipid metabolism. They belong to the nuclear receptor superfamily and are activated by cholesterol derivatives. They have been implicated in preeclampsia because they modulate trophoblast invasion and regulate the expression of the endoglin (CD105) gene, a marker of preeclampsia. The aim of this study was to investigate associations between the <it>NR1H3 </it>and <it>NR1H2 </it>genes and preeclampsia.</p> <p>Methods</p> <p>We assessed associations between single nucleotide polymorphisms of <it>NR1H3 </it>(rs2279238 and rs7120118) and <it>NR1H2 </it>(rs35463555 and rs2695121) and the disease in 155 individuals with preeclampsia and 305 controls. Genotypes were determined by high-resolution melting analysis. We then used a logistic regression model to analyze the different alleles and genotypes for those polymorphisms as a function of case/control status.</p> <p>Results</p> <p>We found no association between <it>NR1H3 </it>SNPs and the disease, but the <it>NR1H2 </it>polymorphism rs2695121 was found to be strongly associated with preeclampsia (genotype C/C: adjusted odds ratio, 2.05; 95% CI, 1.04-4.05; <it>p </it>= 0.039 and genotype T/C: adjusted odds ratio, 1.85; 95% CI, 1.01-3.42; <it>p </it>= 0.049).</p> <p>Conclusions</p> <p>This study provides the first evidence of an association between the <it>NR1H2 </it>gene and preeclampsia, adding to our understanding of the links between cholesterol metabolism and this disease.</p

Decidual-Secreted Factors Alter Invasive Trophoblast Membrane and Secreted Proteins Implying a Role for Decidual Cell Regulation of Placentation

Inadequate or inappropriate implantation and placentation during the establishment of human pregnancy is thought to lead to first trimester miscarriage, placental insufficiency and other obstetric complications. To create the placental blood supply, specialized cells, the ‘extravillous trophoblast’ (EVT) invade through the differentiated uterine endometrium (the decidua) to engraft and remodel uterine spiral arteries. We hypothesized that decidual factors would regulate EVT function by altering the production of EVT membrane and secreted factors. We used a proteomics approach to identify EVT membrane and secreted proteins regulated by decidual cell factors. Human endometrial stromal cells were decidualized in vitro by treatment with estradiol (10−8 M), medroxyprogesterone acetate (10−7 M) and cAMP (0.5 mM) for 14 days. Conditioned media (CM) was collected on day 2 (non-decidualized CM) and 14 (decidualized CM) of treatment. Isolated primary EVT cultured on Matrigel™ were treated with media control, non-decidualized or decidualized CM for 16 h. EVT CM was fractionated for proteins <30 kDa using size-exclusion affinity nanoparticles (SEAN) before trypsin digestion and HPLC-MS/MS. 43 proteins produced by EVT were identified; 14 not previously known to be expressed in the placenta and 12 which had previously been associated with diseases of pregnancy including preeclampsia. Profilin 1, lysosome associated membrane glycoprotein 1 (LAMP1), dipeptidyl peptidase 1 (DPP1/cathepsin C) and annexin A2 expression by interstitial EVT in vivo was validated by immunhistochemistry. Decidual CM regulation in vitro was validated by western blotting: decidualized CM upregulated profilin 1 in EVT CM and non-decidualized CM upregulated annexin A2 in EVT CM and pro-DPP1 in EVT cell lysate. Here, non-decidualized factors induced protease expression by EVT suggesting that non-decidualized factors may induce a pro-inflammatory cascade. Preeclampsia is a pro-inflammatory condition. Overall, we have demonstrated the potential of a proteomics approach to identify novel proteins expressed by EVT and to uncover the mechanisms leading to disease states

Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

BACKGROUND: Genome-wide association studies (GWAS) have so far reported 12 loci associated with serous epithelial ovarian cancer (EOC) risk. We hypothesized that some of these loci function through nearby transcription factor (TF) genes and that putative target genes of these TFs as identified by coexpression may also be enriched for additional EOC risk associations. METHODS: We selected TF genes within 1 Mb of the top signal at the 12 genome-wide significant risk loci. Mutual information, a form of correlation, was used to build networks of genes strongly coexpressed with each selected TF gene in the unified microarray dataset of 489 serous EOC tumors from The Cancer Genome Atlas. Genes represented in this dataset were subsequently ranked using a gene-level test based on results for germline SNPs from a serous EOC GWAS meta-analysis (2,196 cases/4,396 controls). RESULTS: Gene set enrichment analysis identified six networks centered on TF genes (HOXB2, HOXB5, HOXB6, HOXB7 at 17q21.32 and HOXD1, HOXD3 at 2q31) that were significantly enriched for genes from the risk-associated end of the ranked list (P < 0.05 and FDR < 0.05). These results were replicated (P < 0.05) using an independent association study (7,035 cases/21,693 controls). Genes underlying enrichment in the six networks were pooled into a combined network. CONCLUSION: We identified a HOX-centric network associated with serous EOC risk containing several genes with known or emerging roles in serous EOC development. IMPACT: Network analysis integrating large, context-specific datasets has the potential to offer mechanistic insights into cancer susceptibility and prioritize genes for experimental characterization